Literature DB >> 11162473

Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.

T I Orban1, E Olah.   

Abstract

Disrupting the function of the BRCA1 gene by mechanisms other than germline mutations is suspected to occur in cases of sporadic breast/ovarian cancers. Using ribonuclease protection assay and multiplex RT-PCR, we examined the change of the total BRCA1 mRNA pool and the expression profile of four predominant BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell populations compared to normal breast cells. Experiments were carried out on MCF-7 and MDA-MB-231 breast cancer, OVCAR-5 ovarian cancer, and K562 leukemia cell lines. The ratio of the full length, the delta(11q), the delta(9,10), and the delta(9,10,11q) BRCA1 isoforms showed different expression patterns in the examined breast and ovarian tumor cell lines as compared to the leukemia cell line. This observation raises the possibility that the dysregulation of alternative splicing of the BRCA1 gene could be involved in tumor formation in the breast and the ovary, even in the absence of germline mutations. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162473     DOI: 10.1006/bbrc.2000.4068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  Emerging roles of BRCA1 alternative splicing.

Authors:  T I Orban; E Olah
Journal:  Mol Pathol       Date:  2003-08

2.  Quantitative surface-enhanced Raman for gene expression estimation.

Authors:  Lan Sun; Joseph Irudayaraj
Journal:  Biophys J       Date:  2009-06-03       Impact factor: 4.033

Review 3.  Aberrant RNA splicing and its functional consequences in cancer cells.

Authors:  James D Fackenthal; Lucy A Godley
Journal:  Dis Model Mech       Date:  2008 Jul-Aug       Impact factor: 5.758

4.  BRCA1 exon 11 a model of long exon splicing regulation.

Authors:  Michela Raponi; Lindsay D Smith; Marco Silipo; Cristiana Stuani; Emanuele Buratti; Diana Baralle
Journal:  RNA Biol       Date:  2014-03-18       Impact factor: 4.652

5.  Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins.

Authors:  Yunlong Qin; Jingyao Xu; Kartik Aysola; Nurjahan Begum; Vaishali Reddy; Yuli Chai; William E Grizzle; Edward E Partridge; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

6.  Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

Authors:  Phillip J Whiley; Miguel de la Hoya; Mads Thomassen; Alexandra Becker; Rita Brandão; Inge Sokilde Pedersen; Marco Montagna; Mireia Menéndez; Francisco Quiles; Sara Gutiérrez-Enríquez; Kim De Leeneer; Anna Tenés; Gemma Montalban; Demis Tserpelis; Toshio Yoshimatsu; Carole Tirapo; Michela Raponi; Trinidad Caldes; Ana Blanco; Marta Santamariña; Lucia Guidugli; Gorka Ruiz de Garibay; Ming Wong; Mariella Tancredi; Laura Fachal; Yuan Chun Ding; Torben Kruse; Vanessa Lattimore; Ava Kwong; Tsun Leung Chan; Mara Colombo; Giovanni De Vecchi; Maria Caligo; Diana Baralle; Conxi Lázaro; Fergus Couch; Paolo Radice; Melissa C Southey; Susan Neuhausen; Claude Houdayer; Jim Fackenthal; Thomas Van Overeem Hansen; Ana Vega; Orland Diez; Rien Blok; Kathleen Claes; Barbara Wappenschmidt; Logan Walker; Amanda B Spurdle; Melissa A Brown
Journal:  Clin Chem       Date:  2013-11-08       Impact factor: 8.327

7.  PCR-free quantification of multiple splice variants in a cancer gene by surface-enhanced Raman spectroscopy.

Authors:  Lan Sun; Joseph Irudayaraj
Journal:  J Phys Chem B       Date:  2009-10-22       Impact factor: 2.991

8.  Investigation of FJ 194940.1 gene alternative splicing in colon cancer and its association with clinicopathological parameters.

Authors:  Malwina Bartczak-Tomczyk; Aleksandra Sałagacka; Marek Mirowski; Ewa Balcerczak
Journal:  Exp Ther Med       Date:  2011-11-09       Impact factor: 2.447

9.  Alternative splicing and tumor progression.

Authors:  Claudia Ghigna; Cristina Valacca; Giuseppe Biamonti
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

10.  Clustering of sebaceous gland carcinoma, papillary thyroid carcinoma and breast cancer in a woman as a new cancer susceptibility disorder: a case report.

Authors:  Brian D Newman; Joseph F Maher; Jose S Subauste; Gabriel I Uwaifo; Steven A Bigler; Christian A Koch
Journal:  J Med Case Rep       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.